Acetaminophen
Half-Life (t½) PO: 2.5h · IV: 2.5h
Formula C8H9NO2
Molecular Weight 151.16 g/mol
Aliases Paracetamol, Tylenol, Panadol, N-acetyl-para-aminophenol, APAP Pharmacological Mechanism Analgesic + antipyretic action without meaningful peripheral anti-inflammatory or antiplatelet effect. Central arachidonic acid cascade COX-2 inhibition is one hypothesis; additional contribution from active metabolite AM404 (formed in CNS by FAAH) acting on endocannabinoid system + TRPV1 systems. ~90% of dose conjugated (glucuronide + sulfate); ~5% oxidised by CYP2E1 to the hepatotoxic metabolite NAPQI, normally detoxified by glutathione — overwhelmed in overdose or glutathione-depleted states (chronic alcohol, fasting, malnutrition). nac is the antidote via glutathione repletion.
Half-Life & Elimination Curve (PO: 2.5h · IV: 2.5h) 100% 50% 25% 12.5% 0% 0h 0×t½ 2.5h 1×t½ 5h 2×t½ 7.5h 3×t½ 10h 4×t½ 12.5h 5×t½ 0×t½ (0h): 100% remaining (~7.44 mg/L) 1×t½ (2.5h): 50% remaining (~3.72 mg/L) 2×t½ (5h): 25% remaining (~1.86 mg/L) 3×t½ (7.5h): 12.5% remaining (~0.929 mg/L) 4×t½ (10h): 6.3% remaining (~0.465 mg/L) 5×t½ (12.5h): 3.1% remaining (~0.232 mg/L) Plasma (PO) t½ Decay (2.5h) Effect Site (ke0)
0×t½ 0h 100% (7.44 mg/L) 1×t½ 2.5h 50% (3.72 mg/L) 2×t½ 5h 25% (1.86 mg/L) 3×t½ 7.5h 12.5% (0.929 mg/L) 4×t½ 10h 6.3% (0.465 mg/L) 5×t½ 12.5h 3.1% (0.232 mg/L) Dosing Guidelines Oral (PO): Typical 667 mg (Range: 500–1000 mg)Intravenous (IV): Typical 667 mg (Range: 500–1000 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 88% · Volume of Distribution (Vd): 60 L · Absorption (ka): 2.5 h⁻¹ (t½ka ≈ 17m) [PMID 18759860 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 60 L [PMID 18759860 ]Effect-Site Equilibration (ke0): 2.04 h⁻¹ (equilibration half-time t½ke0 ≈ 20m) [PMID 30117229 ]Receptor Binding & Occupancy Pathways It Modulates Target Organ Systems digestive Immune & Hematologic Interactions Warfarin (caution): Chronic APAP ≥2 g/d raises INR modestly (mechanism unclear — possibly CYP2C9 substrate competition). Dose-related; intermittent low-dose use is generally safe. [Holbrook 2005]Alcohol (major): Chronic alcohol induces CYP2E1 → more NAPQI + depleted glutathione → hepatotoxicity at lower APAP doses. Limit APAP to ≤2 g/d in heavy drinkers. [Zimmerman 1995]Ibuprofen / NSAIDs (synergistic): Complementary mechanisms — APAP + ibuprofen outperforms either alone for post-op/dental pain.Chemical Structure & Identifiers InChIKey: RZVAJINKPMORJF-UHFFFAOYSA-NSMILES: CC(=O)NC1=CC=C(C=C1)OReferences Directory Compounds Registry Human Biology Hub